LATE PCR | GenomeWeb

LATE PCR

Scientists from Stellenbosch University in South Africa have been awarded $131,000 from the National Institutes of Health for the first year of a planned four-year project aimed at developing and evaluating a molecular assay for multi- and extreme-drug-resistant tuberculosis usin

Smiths Detection Diagnostics and Novartis Diagnostics plan to develop and market highly multiplexed assays for a variety of infectious diseases, beginning with a focus on healthcare-associated infections.

Novartis Diagnostics will take the Bio-Seeq molecular diagnostic tests for infectious disease through clinical trials and on to commercialization.

The company will use $2.2 million to develop a PCR-based multiple flu test.

The UK-based company will offer the toolkit through a single license that combines IP it licensed from Brandeis University and PHRI Properties, the tech-transfer arm of the University of Medicine and Dentistry of New Jersey.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.